Literature DB >> 7781442

Small bowel bacterial overgrowth in patients with alcoholic cirrhosis.

F C Morencos1, G de las Heras Castaño, L Martín Ramos, M J López Arias, F Ledesma, F Pons Romero.   

Abstract

A total of 89 patients with alcoholic cirrhosis and 40 healthy subjects were included in a study to assess the prevalence of intestinal bacterial overgrowth and to analyze its relationship with the severity of liver dysfunction, presence of ascites, and development of spontaneous bacterial peritonitis (SBP). Bacterial overgrowth was measured by means of a breath test after ingestion of glucose. Intestinal bacterial overgrowth was documented in 27 (30.3%) of the 89 patients with alcoholic cirrhosis and in none of the healthy subjects. The prevalence of intestinal bacterial overgrowth was significantly higher in cirrhotics with ascites (37.1%) than in those with no evidence of ascites (5.3%) and among patients with Pugh-Child class C (48.3%) than in patients with class A (13.1%) or B (27%). Twelve (17.1%) of the 70 patients with ascites developed an episode of SBP. The prevalence of spontaneous bacterial peritonitis was significantly higher in patients who had intestinal bacterial overgrowth (30.7%) than in patients who did not (9.09%). We conclude that intestinal bacterial overgrowth occurs in approximately one third of patients with cirrhosis secondary to alcohol, particularly in patients with ascites and advanced liver dysfunction. Moreover, bacterial overgrowth may be a condition favoring infection of the ascitic fluid.

Entities:  

Mesh:

Year:  1995        PMID: 7781442     DOI: 10.1007/bf02065533

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  28 in total

1.  Natural killer cell activity in alcoholic cirrhosis: influence of nutrition.

Authors:  F Ledesma; S Echevarria; F Casafont; J L Lozano; F Pons-Romero
Journal:  Eur J Clin Nutr       Date:  1990-10       Impact factor: 4.016

2.  Gastrointestinal transit of solid-liquid meal in chronic alcoholics.

Authors:  M Wegener; J Schaffstein; U Dilger; C Coenen; B Wedmann; G Schmidt
Journal:  Dig Dis Sci       Date:  1991-07       Impact factor: 3.199

3.  [Effect of chronic alcohol drinking and liver cirrhosis on oro-cecal transit time (H2 breath test)].

Authors:  D Hüppe; R Tönissen; M Hofius; H D Kuntz; B May
Journal:  Z Gastroenterol       Date:  1989-10       Impact factor: 2.000

4.  The process of microbial translocation.

Authors:  J W Alexander; S T Boyce; G F Babcock; L Gianotti; M D Peck; D L Dunn; T Pyles; C P Childress; S K Ash
Journal:  Ann Surg       Date:  1990-10       Impact factor: 12.969

5.  Bacterial translocation from the gut: a mechanism of infection.

Authors:  E A Deitch; R Berg
Journal:  J Burn Care Rehabil       Date:  1987 Nov-Dec

6.  Jejunoileal bypass for morbid obesity. Late follow-up in 100 cases.

Authors:  M P Hocking; M C Duerson; J P O'Leary; E R Woodward
Journal:  N Engl J Med       Date:  1983-04-28       Impact factor: 91.245

7.  Endotoxemia and bacteremia during hemorrhagic shock. The link between trauma and sepsis?

Authors:  B F Rush; A J Sori; T F Murphy; S Smith; J J Flanagan; G W Machiedo
Journal:  Ann Surg       Date:  1988-05       Impact factor: 12.969

8.  A prospective study of bacterial infections in patients with cirrhosis.

Authors:  W R Caly; E Strauss
Journal:  J Hepatol       Date:  1993-07       Impact factor: 25.083

9.  Small intestinal transit in the portal hypertensive rat.

Authors:  J A Reilly; E M Quigley; C F Forst; L F Rikkers
Journal:  Gastroenterology       Date:  1991-03       Impact factor: 22.682

10.  Bacterial translocation in the portal-hypertensive rat: studies in basal conditions and on exposure to hemorrhagic shock.

Authors:  W T Sorell; E M Quigley; G Jin; T J Johnson; L F Rikkers
Journal:  Gastroenterology       Date:  1993-06       Impact factor: 22.682

View more
  35 in total

1.  Post-feeding hyperammonaemia in patients with transjugular intrahepatic portosystemic shunt and liver cirrhosis: role of small intestinal ammonia release and route of nutrient administration.

Authors:  M Plauth; A E Roske; P Romaniuk; E Roth; R Ziebig; H Lochs
Journal:  Gut       Date:  2000-06       Impact factor: 23.059

2.  Small Bowel Bacterial Overgrowth: Presentation, Diagnosis, and Treatment.

Authors:  Virmeet V. Singh; Phillip P. Toskes
Journal:  Curr Treat Options Gastroenterol       Date:  2004-02

3.  Intestinal barrier dysfunction in cirrhosis: Current concepts in pathophysiology and clinical implications.

Authors:  Georgios I Tsiaoussis; Stelios F Assimakopoulos; Athanassios C Tsamandas; Christos K Triantos; Konstantinos C Thomopoulos
Journal:  World J Hepatol       Date:  2015-08-18

Review 4.  Gut flora and bacterial translocation in chronic liver disease.

Authors:  John Almeida; Sumedha Galhenage; Jennifer Yu; Jelica Kurtovic; Stephen M Riordan
Journal:  World J Gastroenterol       Date:  2006-03-14       Impact factor: 5.742

5.  Dietary fat sources differentially modulate intestinal barrier and hepatic inflammation in alcohol-induced liver injury in rats.

Authors:  Wei Zhong; Qiong Li; Guoxiang Xie; Xiuhua Sun; Xiaobing Tan; Xinguo Sun; Wei Jia; Zhanxiang Zhou
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-10-10       Impact factor: 4.052

6.  Granulocyte elastase in cirrhotic patients with spontaneous bacterial peritonitis.

Authors:  F Casafont; M Rivero; M D Fernandez; J Crespo; E Fabrega; E Sánchez; F Pons-Romero
Journal:  Dig Dis Sci       Date:  1999-10       Impact factor: 3.199

7.  Patients with autonomic neuropathy are more likely to develop hepatic encephalopathy.

Authors:  Anurag Maheshwari; Anil Thomas; Paul J Thuluvath
Journal:  Dig Dis Sci       Date:  2004-10       Impact factor: 3.199

Review 8.  Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis.

Authors:  Valerio Giannelli; Vincenza Di Gregorio; Valerio Iebba; Michela Giusto; Serena Schippa; Manuela Merli; Ulrich Thalheimer
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

9.  Small intestinal bacterial overgrowth in cirrhosis: systematic review and meta-analysis.

Authors:  Roman Maslennikov; Chavdar Pavlov; Vladimir Ivashkin
Journal:  Hepatol Int       Date:  2018-10-04       Impact factor: 6.047

10.  Comparison of rifaximin and lactulose for the treatment of hepatic encephalopathy: a prospective randomized study.

Authors:  Yong Han Paik; Kwan Sik Lee; Kwang Hyub Han; Kun Hoon Song; Myoung Hwan Kim; Byung Soo Moon; Sang Hoon Ahn; Se Joon Lee; Hyo Jin Park; Dong Ki Lee; Chae Yoon Chon; Sang In Lee; Young Myoung Moon
Journal:  Yonsei Med J       Date:  2005-06-30       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.